📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
1 analysed today
FollowTelegram
1
Today
151,860
All-time analysed
43,535
Positive
6,743
Negative
92,745
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
270 announcements match the current filters (relevance ≥ 5).
Blue Star Recommends Final Dividend of ₹8.50 Per Share for FY26
Blue Star Limited has recommended a final dividend of ₹8.50 per equity share of face value ₹2 for the financial year ended March 31, 2026. The company has established July 17, 2026, as the record date to determine shareholder eligibility for the payout. The dividend is subject to approval at the 78th Annual General Meeting scheduled for August 6, 2026, with payments commencing thereafter. This announcement follows the approval of audited financial results for FY26, which received an unmodified audit report.
Key Highlights
Recommended a final dividend of ₹8.50 per equity share for the financial year ended March 31, 2026.
The record date for determining dividend eligibility is fixed as Friday, July 17, 2026.
Dividend payment or dispatch will occur after the Annual General Meeting on August 6, 2026.
Statutory auditors Deloitte Haskins & Sells LLP issued an unmodified audit report for FY26 results.
👀 What to Watch
Investors seeking dividend income should ensure they hold the stock before the record date of July 17, 2026. The dividend recommendation signals management's confidence in the company's cash flow and financial stability.
Blue Star Recommends ₹8.5 Final Dividend for FY26; Sets Record Date for July 17, 2026
Blue Star Limited has recommended a final dividend of ₹8.5 per equity share of face value ₹2 for the financial year ended March 31, 2026. The company has fixed July 17, 2026, as the record date to determine the eligibility of shareholders for the dividend payout. This recommendation is subject to shareholder approval at the 78th Annual General Meeting scheduled for August 6, 2026. Upon approval, the dividend will be dispatched to eligible members starting from August 6, 2026.
Key Highlights
Recommended a final dividend of ₹8.5 per equity share (425% of face value ₹2).
Fixed Friday, July 17, 2026, as the Record Date for dividend eligibility.
The 78th Annual General Meeting (AGM) is scheduled for August 6, 2026.
Dividend payment will be processed after August 6, 2026, following AGM approval.
Statutory Auditors Deloitte Haskins & Sells LLP issued an unmodified audit report for FY26.
👀 What to Watch
Investors seeking to receive the ₹8.5 dividend should ensure they hold the shares in their demat accounts before the ex-dividend date, which is typically one business day prior to the July 17 record date.
Five-Star Business Finance Q4 FY26: PAT at ₹269 Cr; Targets 20% AUM Growth in FY27
Five-Star Business Finance reported a stable Q4 FY26 with a PAT of ₹269 crores and a full-year profit of ₹1,099 crores, up 2% YoY. The company successfully navigated asset quality headwinds, with slippage ratios dropping significantly from 1.9% to 0.7% and unique customer collection efficiency reaching 98.1%. Management has guided for a robust 20% AUM growth in FY27, supported by a $100 million funding line from the Asian Development Bank. Despite a slight sequential dip in quarterly PAT due to higher personnel costs, the company maintained a healthy ROA of 8.68% and ROE of 16%.
Key Highlights
Full-year FY26 PAT grew 2% YoY to ₹1,099 crores with a healthy ROE of 16% and ROA of 8.68%.
Asset quality showed sharp recovery as the slippage ratio dropped to 0.7% from 1.9% in the previous quarter.
Q4 disbursements rose 24% QoQ to ₹1,213 crores, contributing to an 11% annual portfolio growth during a challenging year.
Secured a $100 million line from ADB, helping reduce the overall cost of funds to 8.95% in Q4.
Management issued guidance for 20% AUM growth in FY27 with credit costs expected to improve to 1.7%-1.75%.
👀 What to Watch
Investors should take confidence in the stabilizing asset quality and the management's pivot back to growth with a 20% AUM target. The successful fundraise from ADB and improving collection metrics suggest the worst of the credit cycle is over for the lender.
Blue Star FY26 Revenue Up 3.6% to ₹12,402 Cr; Q4 Net Profit Rises 17% to ₹227 Cr
Blue Star reported a modest 3.6% revenue growth for FY26 at ₹12,402 crores, despite a challenging year where unseasonal rains impacted the Room AC business. While full-year net profit declined to ₹527 crores due to higher finance costs and lower other income, Q4 performance was strong with a 17.1% growth in net profit. The Electro-Mechanical Projects segment showed resilience with 12.8% growth, and the order book remains healthy at ₹6,923 crores. The company recommended a dividend of ₹8.5 per share, slightly lower than the previous year's ₹9.
Key Highlights
FY26 Revenue grew 3.6% to ₹12,402 crores, while PBIDTA (excl. other income) rose 6.2% to ₹930 crores.
Q4FY26 Net Profit surged 17.1% YoY to ₹227.18 crores, driven by record quarterly revenue in the Room AC segment.
The carried-forward order book grew by 10.5% to ₹6,923 crores, providing strong revenue visibility for the upcoming year.
Unitary Products revenue declined 5.1% for the full year due to a weak summer in 2025, but saw a recovery in Q4.
Net cash balance decreased significantly to ₹175.45 crores from ₹640.35 crores due to higher working capital requirements.
👀 What to Watch
Investors should monitor the recovery in the Room AC segment during the current summer season and the execution of the robust order book. While Q4 was strong, the decline in full-year profit and cash reserves suggests a need to watch margin pressures from rising input costs.
Blue Star Recommends ₹8.5 Final Dividend; Approves FY26 Audited Results
Blue Star Limited's Board has recommended a final dividend of ₹8.5 per equity share for the financial year ended March 31, 2026. The company approved its audited standalone and consolidated financial results for FY26, which received an unmodified audit report from Deloitte. The record date for dividend eligibility is set for July 17, 2026, with the 78th Annual General Meeting scheduled for August 6, 2026. Dividend payments are expected to be dispatched after the conclusion of the AGM.
Key Highlights
Recommended a final dividend of ₹8.5 per equity share with a face value of ₹2 each.
Set July 17, 2026, as the record date for determining shareholder eligibility for the dividend.
Approved audited standalone and consolidated financial results for the full year ended March 31, 2026.
Statutory auditors issued an unmodified audit report, confirming the reliability of the financial statements.
The 78th Annual General Meeting (AGM) is scheduled to be held on August 6, 2026.
👀 What to Watch
Investors should ensure they hold the shares by the record date of July 17, 2026, to be eligible for the ₹8.5 dividend payout. The unmodified audit report and dividend recommendation signal stable financial health and shareholder focus.
Star Health FY26 PAT Rises 16% to ₹911 Cr; GWP Crosses ₹20,000 Cr Milestone
Star Health reported a strong financial performance for FY26, with Gross Written Premium (GWP) growing 16% to ₹20,369 crore. The company achieved a significant turnaround in underwriting, posting a profit of ₹206 crore compared to a loss of ₹165 crore in FY25. Net profit (PAT) increased 16% YoY to ₹911 crore, while normalized PAT (at 8% yield) surged 45% to ₹1,222 crore. The combined ratio improved to 98.8% from 101.1%, reflecting better loss management and operating leverage.
Key Highlights
Gross Written Premium (GWP) grew 16% YoY to ₹20,369 crore, crossing a major milestone.
Combined ratio improved by 230 basis points to 98.8% in FY26 from 101.1% in FY25.
Loss ratio saw a 200 bps improvement to 68.7% for the full year, with Q4 loss ratio at 65.2%.
Maintained dominant retail market share of 31.3% with 90% of retail business from proprietary channels.
Normalized Return on Equity (ROE) expanded significantly to 13.1% in FY26 from 10.1% in FY25.
👀 What to Watch
Investors should take note of the successful turnaround in underwriting profitability and the consistent improvement in loss ratios across quarters. The company's market leadership and shift towards a more profitable retail mix make it a strong play in the expanding health insurance sector.
Megastar Foods Wins Relief as ₹73.37 Crore Fee Demand is Quashed by Mandi Board
Megastar Foods Limited has received a major favorable ruling from the Punjab State Agricultural Marketing Board regarding a previous notice from the Market Committee, Rupnagar. The authority has quashed a demand for alleged non-payment of Market Committee and Rural Development Fund (RDF) fees totaling ₹73.37 crore. The licensing authority found the allegations to be baseless and unjustified, directing the local committee to dispose of the matter. This effectively removes a significant potential financial liability from the company's books.
Key Highlights
Punjab State Mandi Board quashed the notice alleging non-payment of statutory fees.
The total demand quashed amounts to ₹73.37 crore, consisting of ₹36.68 crore in Market Fees and ₹36.68 crore in RDF.
The Licensing Authority officially termed the previous allegations as 'baseless and unjustified'.
Company expects to be fully absolved of all financial obligations related to this specific notice.
No impact on operations or financial activities is expected following this resolution.
👀 What to Watch
This is a significant positive development as it eliminates a major regulatory overhang and potential liability. Investors should view this as a strengthening of the company's financial position and a resolution of a key legal risk.
Star Health FY26 PAT Rises 16% to ₹911 Cr; Combined Ratio Improves to 98.8%
Star Health reported a steady performance for FY26, with Gross Written Premium growing 16% YoY to ₹20,369 crore. The company's profitability improved, with IND AS PAT rising 16% to ₹911 crore and normalized PAT jumping 45% to ₹1,222 crore. Operational efficiency was evident as the combined ratio improved from 101.1% to 98.8%, driven by a lower loss ratio of 68.7%. Despite a Q4 loss due to significant mark-to-market investment hits, the core underwriting business remains robust with a 99% renewal ratio.
Key Highlights
Gross Written Premium (GWP) grew 16% YoY to ₹20,369 crore in FY26.
Combined Ratio improved significantly to 98.8% from 101.1% in the previous year.
Retail health renewal ratio reached a high of 99%, up from 97% in FY25.
Agency network expanded to 8.3 lakh agents, contributing to 37% fresh retail growth.
Solvency ratio remains strong at 2.05x, well above the regulatory requirement.
👀 What to Watch
Investors should focus on the improving combined ratio and strong renewal persistency, which indicate high customer loyalty and better underwriting. The Q4 loss is primarily due to non-cash MTM investment adjustments rather than core business weakness.
Star Health FY26 PAT Rises 16% to ₹911 Cr; Combined Ratio Improves to 98.8%
Star Health reported a 16% YoY growth in Gross Written Premium (GWP) to ₹20,369 crore for FY26, driven by a 37% surge in retail fresh business. The company's Profit After Tax (PAT) under IND AS stood at ₹911 crore, while normalized PAT saw a robust 45% growth to ₹1,222 crore. Operational efficiency improved as the Combined Ratio dropped from 101.1% to 98.8%, and the Loss Ratio decreased to 68.7% from 70.7% YoY. The company maintained a strong solvency ratio of 2.05x and achieved a high renewal persistency of 99%.
Key Highlights
Gross Written Premium (GWP) grew 16% YoY to ₹20,369 crore in FY26
Combined Ratio improved to 98.8% from 101.1% in the previous fiscal year
Retail fresh GWP growth recorded at 37% YoY with a 99% renewal persistency ratio
Underwriting profit turned positive at ₹206 crore compared to a loss of ₹165 crore in FY25
Agency force increased to 8.3 lakh agents, with digital channel GWP growing 35% YoY to ₹928 crore
👀 What to Watch
Investors should monitor the continued improvement in the combined ratio and the company's ability to maintain retail market leadership. The shift to positive underwriting profit is a key milestone for long-term value creation.
Five-Star Business Finance FY26 PAT Hits ₹10,988 Mn; Guides 20% AUM Growth for FY27
Five-Star Business Finance reported an 11% YoY growth in AUM to ₹132,246 million for FY26, with a full-year PAT of ₹10,988 million. The company demonstrated resilience with a high NIM of 19.86% and a significant improvement in the slippage ratio, which fell to 0.70% in Q4 from 1.09% in Q3. Management highlighted a record unique customer collection efficiency of 98.1% for the quarter, indicating a recovery in asset quality. Looking ahead, the firm targets a 20% AUM growth for FY27, supported by its expanded network of 844 branches.
Key Highlights
FY26 AUM grew 11% YoY to ₹132,246 million with disbursements of ₹46,757 million.
Full-year PAT reached ₹10,988 million, up 2% YoY, with a healthy ROA of 8.68%.
Gross NPA remained stable at 3.37%, while the slippage ratio improved to 0.70% in Q4.
Net Interest Margin (NIM) remained robust at 19.86% for the full year FY26.
Branch network expanded to 844 across 11 states, adding 96 branches during the fiscal year.
👀 What to Watch
Investors should view the improving slippage ratios and strong collection efficiency as signs of stabilizing asset quality. The management's guidance of 20% AUM growth for FY27 suggests a return to aggressive expansion which could re-rate the stock if execution holds.
Five-Star Business Finance Recommends Final Dividend of ₹2 Per Share (200% of Face Value)
The Board of Directors of Five-Star Business Finance Limited has recommended a final dividend of ₹2 per equity share for the financial year ended March 31, 2026. This payout represents 200% of the face value of ₹1 per share and is subject to shareholder approval at the 42nd Annual General Meeting. The company has established July 31, 2026, as the record date for determining eligible shareholders. Once approved, the dividend will be paid within 30 days of the AGM.
Key Highlights
Recommended final dividend of ₹2 per equity share for FY 2025-26
Dividend payout ratio stands at 200% of the ₹1 face value
Record date for dividend eligibility fixed as Friday, July 31, 2026
Payment to be completed within 30 days from the date of the 42nd AGM
👀 What to Watch
Investors seeking dividend income should maintain their holdings until the record date of July 31, 2026, to be eligible for the payout. Monitor the upcoming AGM for final approval and further management commentary on capital allocation.
Five-Star Business Finance Declares ₹2 Final Dividend; Sets July 31 as Record Date
Five-Star Business Finance has recommended a final dividend of ₹2 per equity share for the financial year ended March 31, 2026. This payout represents 200% of the face value of ₹1 per share. The company has fixed July 31, 2026, as the record date to determine shareholder eligibility for the dividend. The final payout is subject to approval at the upcoming 42nd Annual General Meeting and will be distributed within 30 days of that meeting.
Key Highlights
Recommended a final dividend of ₹2 per equity share for FY 2025-26.
Dividend payout is 200% of the face value of ₹1 per share.
Record date for eligibility is fixed as Friday, July 31, 2026.
Payment to be completed within 30 days from the date of the 42nd Annual General Meeting.
👀 What to Watch
Investors seeking dividend income should ensure they hold the stock prior to the ex-dividend date to qualify for the ₹2 per share payout. The 200% dividend reflects a healthy return of capital to shareholders.
Five-Star Business Finance Extends Tenure of CRO Jayaraman S for 3 Years
Five-Star Business Finance has approved the extension of Mr. Jayaraman S as Chief Risk Officer (CRO) for a further period of three years, effective June 1, 2026. Mr. Jayaraman has been with the company for 5.5 years and has served as the CRO since May 2021. With approximately 28 years of experience in credit, finance, and treasury, his continuation ensures leadership stability in a critical risk management function. This move is aimed at maintaining the company's asset quality and risk oversight standards.
Key Highlights
Tenure of Chief Risk Officer Jayaraman S extended for 3 years starting June 1, 2026
Mr. Jayaraman brings 28 years of professional experience in Credit, Finance, and Treasury
He has been the CRO of Five-Star since May 2021 and with the firm for 5.5 years
Previous experience includes 16 years at Redington in Treasury and Credit Management roles
👀 What to Watch
Investors should view this as a positive sign of management continuity and stability in the company's risk framework. No immediate action is required as this is a routine extension of a proven senior executive.
Five-Star Business Finance Recommends ₹2 Dividend and Approves Audited FY26 Results
Five-Star Business Finance Limited has announced its audited financial results for the fiscal year ending March 31, 2026, with a clean audit report from Deloitte Haskins & Sells. The Board has proposed a final dividend of ₹2 per share, which is 200% of the face value, with a record date set for July 31, 2026. To maintain stability in risk management, the tenure of Chief Risk Officer Mr. Jayaraman S has been extended for three years. These announcements reflect a combination of shareholder returns and management continuity.
Key Highlights
Recommended a final dividend of ₹2 per equity share (200% of face value) for FY26.
Audited financial results for FY26 received an unmodified opinion from statutory auditors.
Fixed July 31, 2026, as the record date for determining dividend eligibility.
Extended the tenure of Chief Risk Officer Mr. Jayaraman S for 3 years effective June 01, 2026.
Confirmed maintenance of 100% or higher security cover for listed debt securities.
👀 What to Watch
Investors should note the dividend record date of July 31, 2026, and view the management continuity in the risk department as a positive sign for asset quality stability.
Star Health FY26 PAT Rises 16% to INR 911 Cr; Underwriting Turns Profitable
Star Health reported a strong financial performance for FY26, with Profit After Tax (PAT) growing 16% YoY to INR 911 Crores. The company achieved a significant turnaround in underwriting, posting a profit of INR 206 Crores compared to a loss of INR 165 Crores in the previous year. Gross Written Premium grew by 16% to INR 20,369 Crores, driven by a 20% surge in the retail health segment where the company maintains a dominant 31% market share. Key efficiency metrics like the Combined Ratio improved to 98.8%, reflecting better risk selection and operational discipline.
Key Highlights
PAT increased by 16% YoY to INR 911 Crores in FY26 from INR 787 Crores in FY25
Gross Written Premium (GWP) grew 16% to INR 20,369 Crores, with Retail Health growing 20% to INR 19,341 Crores
Combined Ratio improved significantly by 236 bps to 98.8%, moving below the critical 100% threshold
Underwriting performance turned positive with a profit of INR 206 Crores against a loss of INR 165 Crores in FY25
Retail health market share remains strong at 31% with a robust 99% renewal persistency
👀 What to Watch
Investors should note the significant improvement in underwriting profitability and the combined ratio, which indicates a shift toward more sustainable margins. The company's dominant retail market share and high persistency make it a strong long-term play in the health insurance sector.
Star Health FY26 PAT at ₹645.86 Cr; Gross Premium Grows 9.7% to ₹16,741 Cr
Star Health reported a standalone Net Profit of ₹645.86 crore for FY26, a decline from ₹750.98 crore in the previous fiscal year. Despite the annual profit dip, Gross Premium income showed steady growth, rising 9.7% YoY to reach ₹16,741 crore. The company's solvency ratio remains healthy at 2.05, well above the regulatory requirement, though the combined ratio increased slightly to 102.07%, indicating higher claims and operating costs.
Key Highlights
Gross Premium income increased to ₹16,741 crore in FY26 compared to ₹15,251 crore in FY25.
Full-year Net Profit (PAT) stood at ₹645.86 crore, down approximately 14% from ₹750.98 crore YoY.
Solvency ratio remains robust at 2.05x, providing a significant cushion over the 1.50x regulatory mandate.
Combined ratio, a key profitability metric, rose to 102.07% from 100.47% in the previous year.
Earnings Per Share (EPS) for the full year decreased to ₹9.47 from ₹11.01 in FY25.
👀 What to Watch
Investors should monitor the rising combined ratio and its impact on underwriting margins despite steady premium growth. The stock remains a watch as the company balances market share expansion with bottom-line profitability.
IndoStar Capital Finance Allots NCDs Worth ₹600 Crore at 9.25% Coupon
IndoStar Capital Finance Limited has successfully allotted 60,000 senior, secured, rated, and listed Non-Convertible Debentures (NCDs) totaling ₹600 crore via private placement. The issuance is divided into three series (XXXI, XXXII, and XXXIII) with a uniform coupon rate of 9.25% per annum. The tenors for these instruments range from approximately 19 to 21 months, with maturity dates scheduled between November 2027 and January 2028. This capital infusion is expected to support the company's lending operations and liquidity requirements.
Key Highlights
Total fundraise of ₹600 crore through 60,000 NCDs with a face value of ₹1,00,000 each.
Fixed coupon rate of 9.25% per annum across all three series with annual interest payments.
Series XXXI (₹200 cr), Series XXXII (₹125 cr), and Series XXXIII (₹275 cr) have tenors between 18 and 21 months.
Secured by a first pari-passu charge on the company's portfolio assets and receivables.
Redemption dates are set for November 22, 2027, November 23, 2027, and January 24, 2028.
👀 What to Watch
Investors should monitor the company's ability to maintain its Net Interest Margin (NIM) given the 9.25% cost of these funds. The successful placement indicates healthy credit demand and market confidence in the company's debt instruments.
Star Cement Subsidiary to Acquire 100% of Nitesh Minerals for Rs 17.19 Crore
Star Cement's subsidiary, Ri Pnar Cement Private Limited, has entered into a Share Purchase Agreement to acquire 100% of Nitesh Minerals Private Limited for Rs 17.19 crore. The acquisition is aimed at securing a steady supply of limestone, as Nitesh Minerals holds a mining lease. Nitesh Minerals recorded a turnover of Rs 157.22 lakhs in 2025 and Rs 287.07 lakhs in 2024. This strategic move is expected to provide logistical benefits and strengthen the company's backward integration in the cement business.
Key Highlights
Acquisition of 100% stake in Nitesh Minerals Private Limited for Rs 17.19 crore cash consideration.
Strategic move to secure limestone mining leases for uninterrupted raw material supply.
Target company turnover was Rs 157.22 lakhs in 2025, compared to Rs 287.07 lakhs in 2024.
Nitesh Minerals will become a step-down subsidiary of Star Cement Limited.
👀 What to Watch
Investors should view this as a positive strategic move for long-term raw material security. Monitor the impact on logistics costs and operating margins in future earnings reports.
Megastar Foods Receives Rs 73.37 Cr Notice for Alleged Fee Non-Payment; Company to Contest
Megastar Foods Limited has received a notice from the Market Committee, Rupnagar, alleging non-payment of Market Committee and Rural Development Fund (RDF) fees totaling approximately Rs 73.37 crore. The company issued a correction to a previous filing, clarifying that the individual fee amounts are Rs 36.68 crore each, not the erroneously reported Rs 36,568 crore. Megastar Foods maintains that as a processing unit, it is exempt from these fees under Punjab state laws and holds a valid license until March 2030. The company intends to pursue legal recourse and does not anticipate an immediate financial impact.
Key Highlights
Received notice for alleged non-payment of Market Committee Fee (Rs 36.69 Cr) and RDF Fee (Rs 36.69 Cr).
Total alleged liability is approximately Rs 73.37 crore, which the company is contesting.
Corrected a significant clerical error in a previous disclosure that overstated the claim by over Rs 36,000 crore.
Company holds a valid license from the Punjab State Agricultural Marketing Board until March 31, 2030.
Management claims processing units in Punjab are legally exempt from these specific market fees.
👀 What to Watch
Investors should monitor the outcome of the adjudication proceedings as the claim amount is significant, though the company's legal defense regarding its status as a processing unit appears robust.
Megastar Foods Receives Notice for Alleged Fees of ₹7,313.72 Cr; Company Disputes Claim
Megastar Foods has received a notice from the Market Committee, Rupnagar, alleging non-payment of Market Committee and RDF fees totaling approximately ₹7,313.72 crore. The company contends that it holds a valid license from the Punjab State Agricultural Marketing Board until 2030 and that processing units are exempt from such fees under state law. Management is initiating legal recourse and approaching the appropriate licensing authority to resolve the matter. While the claimed amount is exceptionally high relative to the company's scale, the company is hopeful of a favorable outcome based on its assessment of state statutes.
Key Highlights
Received notice for alleged non-payment of Market Committee Fee (₹3,656.86 Cr) and RDF Fee (₹3,656.86 Cr).
Company maintains it holds a valid license from the Punjab State Agricultural Marketing Board until March 31, 2030.
Management asserts that under Punjab state laws, market fees and RDF are not applicable to processing units.
The company is pursuing legal recourse and approaching the Mandi Board, SAS Nagar, for a resolution.
No immediate financial impact expected as the company contests the validity of the notice.
👀 What to Watch
Investors should monitor the legal developments closely as the claimed amount is significantly higher than the company's market capitalization. However, the situation appears to be a jurisdictional or interpretational dispute that the company is actively contesting.
